Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus
Practicing physicians have requested efficacy and safety data for belimumab, when used with specific systemic lupus erythematosus (SLE) medications. This was a post hoc analysis of pooled efficacy and safety data from patients who received belimumab 10 mg/kg plus standard of care (SoC) or placebo (S...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
SAGE Publications
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089223/ |